WORK Medical Technology Group LTD priced its initial public offering at $0.50 a share, to list on the Nasdaq Capital Market under the symbol WOK. It filed a Form F-1 registration statement for an initial public offering on December 23, 2024. As of November 6, 2026, its final prospectus is on file (Form 424B4, May 22, 2025).
Sell to companies like WORK Medical Technology Group LTD? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · What it is: Final prospectus filed: the offering is priced · 424B4
- · What it is: Registration statement amended (foreign issuer) · F-1/A
- · What it is: Registration statement amended (foreign issuer) · F-1/A
- · What it is: Registration statement filed (foreign issuer) · F-1
- · What it is: Final prospectus filed: the offering is priced · 424B4
WORK Medical Technology Group LTD filed a Form F-1 registration statement for an initial public offering on 2024-12-23. It has amended it 5 times. It filed its final prospectus on 2025-05-22, at a public offering price of $0.50 per share. Each fact below is quoted from the filing named with it.
Also on the record for WORK Medical Technology Group LTD
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| June 16, 2026 | Stake report, Schedule 13G/A, by Habbas Kelly Khalid | — | 5%+ stakes | Source |
| June 10, 2026 | Stake report, Schedule 13G/A, by Habbas Kelly Khalid | 21.5% of the class | 5%+ stakes | Source |
| June 9, 2026 | Stake report, Schedule 13G/A, by Trillium Trading, LLC | — | 5%+ stakes | Source |
| June 8, 2026 | Stake report, Schedule 13G, by Trillium Trading, LLC | 18% of the class | 5%+ stakes | Source |
| June 4, 2026 | Stake report, Schedule 13G, by Habbas Kelly Khalid | 18.9% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by L1 Capital Global Opportunities Master Fund, Ltd. | — | 5%+ stakes | Source |
| October 14, 2025 | Stake report, Schedule 13G/A, by BIGGER CAPITAL FUND L P | — | 5%+ stakes | Source |
| October 3, 2025 | Stake report, Schedule 13G, by L1 Capital Global Opportunities Master Fund, Ltd. | 9.99% of the class | 5%+ stakes | Source |
| September 29, 2025 | Stake report, Schedule 13G, by BIGGER CAPITAL FUND L P | 9.99% of the class | 5%+ stakes | Source |
Check before you invest in WORK Medical Technology Group LTD: the warning signs and who's behind it, free.
Free to see. No signup.
Keep reading
More on WORK Medical Technology Group LTD and the records around it.
WORK Medical Technology Group LTD elsewhere on the record
Companies that share a holder
- BIGGER CAPITAL FUND L P also filed stake reports on 13 other companies: ClearPoint Neuro, Inc. (Nov 2026), Dermata Therapeutics, Inc. (Nov 2026), BTC Digital Ltd. (Oct 2026)
- L1 Capital Global Opportunities Master Fund, Ltd. also filed stake reports on 42 other companies: Youlife Group Inc. (Nov 2026), INLIF Ltd (Oct 2026), DarkIris Inc. (Oct 2026)
Also filing to list on the Nasdaq Capital Market
IPO filings on the Nasdaq Capital Market in Q2 2025, newest first.
- Julong Holding Ltd (Jun 2025)
- HW Electro Co., Ltd. (Jun 2025)
- PicoCELA Inc. (May 2025)
Watch WORK Medical Technology Group LTD
Get an email when WORK Medical Technology Group LTD files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on WORK Medical Technology Group LTD?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on WORK Medical Technology Group LTD: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on WORK Medical Technology Group LTD covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
17 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
What the filings say
Listing
Our Class A Ordinary Shares are listed on the Nasdaq Capital Market under the symbol “WOK.”From the 424B4 filed 2025-05-22
Shares offered
16,999,442 Class A Ordinary Shares, assuming no sale of Pre -Funded Ordinary Units, which, if sold, would reduce the number of Ordinary Units that we are offering on a one -for-one basis, and no exercise of the Warrants, and 7,592,500 Class B Ordinary Shares.From the 424B4 filed 2025-05-22
Offering price
We are offering the Ordinary Units at the public offering price of $0.50 per Ordinary Unit.From the 424B4 filed 2025-05-22
Use of proceeds
We plan to use the net proceeds we receive from this offering for the following purposes:From the 424B4 filed 2025-05-22
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2024-07-05 | Registration statement amended (foreign issuer) | F-1/A |
| 2024-07-17 | Registration statement amended (foreign issuer) | F-1/A |
| 2024-08-02 | Registration statement amended (foreign issuer) | F-1/A |
| 2024-08-26 | Final prospectus filed: the offering is priced | 424B4 |
| 2024-12-23 | Registration statement filed (foreign issuer) | F-1 |
| 2025-04-09 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-04-29 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-05-22 | Final prospectus filed: the offering is priced | 424B4 |
Tools for this story
Each opens in a new tab, filled in for WORK Medical Technology Group LTD. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.